PRINTING
BIOTECHNOLOGIES
IQDEMY BIO
BIOTECHNOLOGIES
IQDEMY BIO
We offer to participate in high-tech social project IQDEMY Bio,
which has already been carried out by our RND team.
which has already been carried out by our RND team.
PRINTING
BIOTECHNOLOGIES
IQDEMY BIO
BIOTECHNOLOGIES
IQDEMY BIO
We offer to participate in high-tech social project IQDEMY Bio, which has already been carried out by our RND team.
TECNOLOGIES OF FUTURE by IQDEMY
IQDEMY BIO (Printing biotechnologies) – a promising high-tech biomedical project, in terms of which are being developed technologies and equipment for printing matrixes, biochemical tissues and organs with living cells, proteins and bacteria, as well as synthetic components for the further use in medicine.
OUR LEADING PROJECTS:
3D Bioprinting of tissues
and organs for human and animals
and organs for human and animals
Technology of 3D models creation on a cellular
basis using 3D printing, which enhances the survival of cells.
basis using 3D printing, which enhances the survival of cells.
3D bioprinting
of the eye cornea / skin
of the eye cornea / skin
We are working on the testing of the developed UV-LED inks based on the gelatin methacrylate (GelMA) and other photocross-linkable materials, also matrixes were printed with our own prototype of bioprinter and they were sowed with the rats fibroblasts. Our R&D team is working now on the testing of bio inks and building up the height of the printed scaffolds and follow-up study of the survival of cells.
Biosynthesizer
for synthesis of DNA RNA
(oligonucleotides with DNA)
for synthesis of DNA RNA
(oligonucleotides with DNA)
Essential advantage of inkjet technology is the high speed of implementation of this process; And we reached the quantitative index: synthesis of "the pool" of oligonucleotides, i.e. there is opportunity to synthesize at the same time the "pool" of oligonucleotides from 1000 to 10 000 for one time.
System rapid test for diagnosis
of diseases with quantum dots
of diseases with quantum dots
Quantum dots allow to reduce considerably the speed of the instant diagnosis. The main objective is to increase sensitivity and specificity to the infectious agent, during the development of rapid tests for screening -one of the widespread diseases are: flu virus, tick-borne encephalitis, causative agent of the diseases, sexually transmitted (STIs), or virus of hepatitis B or C.
Development of the markers
with quantum dots for visualization
in the biomedicine
with quantum dots for visualization
in the biomedicine
Work are being carried out now on the creation of the set: conjugate "Quantum dots + streptavidin". And is being conducted the research on creation of conjugates with quantum dots and monoclonal/ second antibodies for development of ELISA-test systems.
Development of the sets
for diagnostics of genetically
modified product
for diagnostics of genetically
modified product
IQDEMY unique printing technology –
we know how to do it with Quantum Dots!
we know how to do it with Quantum Dots!
3D Bioprinting of tissues
and organs for human and animals
and organs for human and animals
Technology of 3D models creation on a cellular
basis using 3D printing, which enhances the survival of cells.
basis using 3D printing, which enhances the survival of cells.
3D bioprinting
of the eye cornea / skin
of the eye cornea / skin
We are working on the testing of the developed UV-LED inks based on the gelatin methacrylate (GelMA) and other photocross-linkable materials, also matrixes were printed with our own prototype of bioprinter and they were sowed with the rats fibroblasts. Our R&D team is working now on the testing of bio inks and building up the height of the printed scaffolds and follow-up study of the survival of cells.
Biosynthesizer
for synthesis of DNA RNA
(oligonucleotides with DNA)
for synthesis of DNA RNA
(oligonucleotides with DNA)
Essential advantage of inkjet technology is the high speed of implementation of this process; And we reached the quantitative index: synthesis of "the pool" of oligonucleotides, i.e. there is opportunity to synthesize at the same time the "pool" of oligonucleotides from 1000 to 10 000 for one time.
System rapid test for diagnosis
of diseases with quantum dots
of diseases with quantum dots
Quantum dots allow to reduce considerably the speed of the instant diagnosis. The main objective is to increase sensitivity and specificity to the infectious agent, during the development of rapid tests for screening -one of the widespread diseases are: flu virus, tick-borne encephalitis, causative agent of the diseases, sexually transmitted (STIs), or virus of hepatitis B or C.
Development of the markers
with quantum dots for visualization
in the biomedicine
with quantum dots for visualization
in the biomedicine
Work are being carried out now on the creation of the set: conjugate "Quantum dots + streptavidin". And is being conducted the research on creation of conjugates with quantum dots and monoclonal/ second antibodies for development of ELISA-test systems.
Development of the sets
for diagnostics of genetically
modified product
for diagnostics of genetically
modified product
IQDEMY unique printing technology –
we know how to do it with Quantum Dots!
we know how to do it with Quantum Dots!
GOAL OF OFFER
The goal is to take one of the leading place in the world leading suppliers of printing complexes for artificially grown human tissues (or diseases, artificially received under laboratory conditions) for pharmaceutical, cosmetic developments and burn centers, specialized in skin transplantation to 2028 year. This goal will enable the company to take one of the leading roles in sales of artificial tissue models, consisting of several cell types.
INVESTMENT
Initial investments: 50 million €
Initial investments (without recognition of further sales revenue) respond to:
Production facilities and equipment – 15%
Printers and inks production – 11%
Maintenance of production process – 4%
Research and development – 52%
Commercial expenses – 16%
Administrative expenses – 2%
Production facilities and equipment – 15%
Printers and inks production – 11%
Maintenance of production process – 4%
Research and development – 52%
Commercial expenses – 16%
Administrative expenses – 2%
Payback period: 67 months
Royalties: 20% of the shares, €835 million
Royalties: 20% of the shares, €835 million
APPLICATION FORM
ЖМИТЕ НА ИКОНКУ WHATSAPP ИЛИ СКАНИРУЙТЕ QR-КОД СО СВОЕГО СМАРТФОНА, ЧТОБЫ ПЕРЕЙТИ В ЧАТ С БОТОМ
ЖМИТЕ НА ИКОНКУ FACEBOOK MESSENGER ИЛИ СКАНИРУЙТЕ QR-КОД СО СВОЕГО СМАРТФОНА, ЧТОБЫ ПЕРЕЙТИ В ЧАТ С БОТОМ
LEAVE AN APPLICATION AND OUR SPECIALIST WILL SHARE WITH YOU ALL THE DETAILS
Now youll recieve email with KNOW HOW!
Now youll recieve our email!
Вы просмотрели один из шаблонов нашего магазина. Если этот вариант вас устраивает, то вы можете положить его в корзину, нажав на кнопку "Добавить в корзину"
Все фотографии и тексты используются для демонстрации возможностей шаблона страницы. Пожалуйста, не используйте их в коммерческих целях.
Кликните на кнопку, чтобы перейти обратно в магазин
Click to order
ВАШ ЗАКАЗ
Total:
